4.6 Article

Enlarged Hyperechogenic Substantia Nigra Is Related to Motor Performance and Olfaction in the Elderly

Journal

MOVEMENT DISORDERS
Volume 25, Issue 10, Pages 1464-1469

Publisher

WILEY-BLACKWELL
DOI: 10.1002/mds.23114

Keywords

cohort studies; Parkinson's disease/parkinsonism; ultrasound

Funding

  1. Universities of Homburg, Innsbruck, and Tuebingen
  2. BMBF [01GS0116, 01GS08134]
  3. Janssen Pharmaceuticals
  4. TEVA Pharma GmbH
  5. German Parkinson's disease Association
  6. Dr. Werner Jackstadt Foundation
  7. German Research Foundation
  8. Robert and Clarice Smith Fellowship in Neurodegenerative Disease and Stroke Award
  9. American Neurological Association
  10. Movement disorders Society
  11. Mayo Clinic
  12. Michael J. Fox Foundation
  13. Robert Bosch Foundation
  14. Novartis
  15. Helmholtz association
  16. Hertie Foundation
  17. Eisai
  18. Teva
  19. GSK
  20. Boehringer-Ingelheim
  21. UCB
  22. Orion Pharma
  23. Merck Serono
  24. Schering plough

Ask authors/readers for more resources

Enlarged substantia nigra hyperechogenicity (SN+) assessed by transcranial sonography (TCS) may be associated with Parkinson's disease (PD) risk markers such as impaired motor performance and hyposmia. The aim of this multicenter cross-sectional study was to define the association between SN+ and these risk markers in a large population older than 50 years without the diagnosis of PD. In three centers (Tuebingen, Homburg, and Innsbruck), 1,839 individuals were examined. The echostatus of the SN was assessed by TCS, motor performance by the Unified Parkinson's Disease Rating Scale (UPDRS) motor score, and olfactory function with Sniffin' Sticks. From the 1,603 subjects included in the analysis, 16.2% were SN+, 23.0% scored above zero in the UPDRS motor section, and 28.0% were hyposmic as defined by less than 75% correctly classified Sniffin' Sticks. SN+ was associated with a UPDRS motor score above zero (OR 1.45, 95% CI 1.08-1.96) and with a lower odor identification capability (OR 1.48, 95% Cl 1.12-1.96). The combination of these two features (OR 1.98, 95% Cl 1.25-3.15) and UPDRS motor scores >= 3 lead to higher OR. It is concluded that SN+, impaired motor performance, and hyposmia are frequently observed in the elderly and in isolation are unspecific and of limited use to predict a subject's risk for PD. Whether the association of SN+ with both impaired motor performance and hyposmia as seen in this study predicts an increased risk for the development of PD needs to be evaluated in the follow-up investigations. (C) 2010 Movement Disorder Society

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available